Roberto Palacios

1.3k total citations
33 papers, 1.0k citations indexed

About

Roberto Palacios is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Roberto Palacios has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Roberto Palacios's work include Hormonal Regulation and Hypertension (11 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers) and Nitric Oxide and Endothelin Effects (6 papers). Roberto Palacios is often cited by papers focused on Hormonal Regulation and Hypertension (11 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers) and Nitric Oxide and Endothelin Effects (6 papers). Roberto Palacios collaborates with scholars based in Spain, France and United Kingdom. Roberto Palacios's co-authors include María J. Alonso, Mercedes Salaíces, Ángela Martín, Raquel Hernanz, Andrea Aguado, Aurélie Nguyen Dinh Cat, Ana M. Briones, Malou Friederich‐Persson, Frédéric Jaisser and Dalton Valentim Vassallo and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Roberto Palacios

32 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Palacios Spain	17	274	219	212	158	147	33	1.0k
Eiji Sugaru Japan	14	242 0.9×	544 2.5×	135 0.6×	306 1.9×	140 1.0×	22	1.3k
Victor V. Lima Brazil	24	561 2.0×	266 1.2×	270 1.3×	322 2.0×	206 1.4×	62	1.4k
María Soledad Avendaño Spain	16	321 1.2×	227 1.0×	98 0.5×	94 0.6×	193 1.3×	25	1.0k
Van Anthony M. Villar United States	25	691 2.5×	244 1.1×	321 1.5×	121 0.8×	349 2.4×	58	1.4k
Kazushi Watanabe Japan	23	536 2.0×	150 0.7×	154 0.7×	123 0.8×	147 1.0×	98	1.8k
Shujun Jiang China	22	467 1.7×	173 0.8×	108 0.5×	134 0.8×	62 0.4×	79	1.3k
Kevin W. Aylor United States	26	537 2.0×	379 1.7×	389 1.8×	91 0.6×	246 1.7×	44	1.6k
Amanda W. Wyatt Germany	16	466 1.7×	209 1.0×	186 0.9×	58 0.4×	142 1.0×	16	978
Marı́a Dolores Mayas Spain	17	276 1.0×	303 1.4×	159 0.8×	45 0.3×	181 1.2×	61	1.1k
Nihar R. Pandey Canada	17	451 1.6×	163 0.7×	116 0.5×	181 1.1×	79 0.5×	22	976

Countries citing papers authored by Roberto Palacios

Since Specialization

Citations

This map shows the geographic impact of Roberto Palacios's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Palacios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Palacios more than expected).

Fields of papers citing papers by Roberto Palacios

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Palacios. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Palacios. The network helps show where Roberto Palacios may publish in the future.

Co-authorship network of co-authors of Roberto Palacios

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Palacios. A scholar is included among the top collaborators of Roberto Palacios based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Palacios. Roberto Palacios is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gabarre, Paul, Roberto Palacios, Kevin Pérez, et al.. (2025). Immunosuppressive drugs and diet interact to modify the gut microbiota and cardiovascular risk factors, and to trigger diabetes. PLoS ONE. 20(3). e0320438–e0320438.

Motiño, Omar, et al.. (2024). Obesity-Associated Colorectal Cancer. International Journal of Molecular Sciences. 25(16). 8836–8836. 13 indexed citations

Lima‐Posada, Ixchel, Roberto Palacios, Benjamin Bonnard, et al.. (2024). Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease. Journal of the American Heart Association. 13(12). e032971–e032971. 7 indexed citations

Horrillo, Daniel, et al.. (2024). Mineralocorticoid Receptor and Sleep Quality in Chronic Kidney Disease. International Journal of Molecular Sciences. 25(22). 12320–12320. 1 indexed citations

Stéphan, Yannick, Ixchel Lima‐Posada, Roberto Palacios, et al.. (2024). Benefit of combination therapy with dapagliflozin and eplerenone on cardiac function and fibrosis in rats with non-diabetic chronic kidney disease. Scientific Reports. 14(1). 23955–23955. 5 indexed citations

Motiño, Omar, et al.. (2023). Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence. International Journal of Molecular Sciences. 24(7). 6374–6374. 18 indexed citations

Durán, M., et al.. (2023). Multiomics insights on the onset, progression, and metastatic evolution of breast cancer. Frontiers in Oncology. 13. 1292046–1292046. 3 indexed citations

Lima‐Posada, Ixchel, Roberto Palacios, Benjamin Bonnard, et al.. (2023). Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction. International Journal of Molecular Sciences. 24(3). 2536–2536. 15 indexed citations

Martinez, Caroline Silveira, Ángela Martín, Roberto Palacios, et al.. (2019). Egg White Hydrolysate: A new putative agent to prevent vascular dysfunction in rats following long-term exposure to aluminum. Food and Chemical Toxicology. 133. 110799–110799. 17 indexed citations

10.

Farman, Nicolette, et al.. (2019). Cutaneous Wound Healing in Diabetic Mice Is Improved by Topical Mineralocorticoid Receptor Blockade. Journal of Investigative Dermatology. 140(1). 223–234.e7. 44 indexed citations

11.

Friederich‐Persson, Malou, Laura Braud, Roberto Palacios, et al.. (2019). MR (Mineralocorticoid Receptor) Induces Adipose Tissue Senescence and Mitochondrial Dysfunction Leading to Vascular Dysfunction in Obesity. Hypertension. 73(2). 458–468. 53 indexed citations

12.

Palacios, Roberto, Raquel Hernanz, Ángela Martín, et al.. (2019). Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway. Scientific Reports. 9(1). 16461–16461. 23 indexed citations

13.

Montezano, Augusto C., Lívia L. Camargo, Patrik Persson, et al.. (2018). NADPH Oxidase 5 Is a Pro‐Contractile Nox Isoform and a Point of Cross‐Talk for Calcium and Redox Signaling‐Implications in Vascular Function. Journal of the American Heart Association. 7(12). 52 indexed citations

14.

Martinez, Caroline Silveira, Ángela Martín, Roberto Palacios, et al.. (2017). Aluminum exposure at human dietary levels promotes vascular dysfunction and increases blood pressure in rats: A concerted action of NAD(P)H oxidase and COX-2. Toxicology. 390. 10–21. 41 indexed citations

15.

Avendaño, María Soledad, Sonia Martínez‐Revelles, Andrea Aguado, et al.. (2016). Role of COX‐2‐derived PGE₂ on vascular stiffness and function in hypertension. British Journal of Pharmacology. 173(9). 1541–1555. 49 indexed citations

16.

Rios, Francisco J., Karla B Neves, Aurélie Nguyen Dinh Cat, et al.. (2015). Cholesteryl Ester-Transfer Protein Inhibitors Stimulate Aldosterone Biosynthesis in Adipocytes through Nox-Dependent Processes. Journal of Pharmacology and Experimental Therapeutics. 353(1). 27–34. 19 indexed citations

17.

Batista, Priscila Rossi de, Roberto Palacios, Ángela Martín, et al.. (2014). Toll-Like Receptor 4 Upregulation by Angiotensin II Contributes to Hypertension and Vascular Dysfunction through Reactive Oxygen Species Production. PLoS ONE. 9(8). e104020–e104020. 101 indexed citations

18.

Pérez-Girón, José Vicente, Roberto Palacios, Ángela Martín, et al.. (2014). Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology. 306(11). H1582–H1593. 23 indexed citations

19.

Hernanz, Raquel, Ángela Martín, José Vicente Pérez-Girón, et al.. (2012). Pioglitazone treatment increases COX‐2‐derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function. British Journal of Pharmacology. 166(4). 1303–1319. 24 indexed citations

20.

Martín, Ángela, José Vicente Pérez-Girón, Raquel Hernanz, et al.. (2011). Peroxisome proliferator-activated receptor-γ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. Journal of Hypertension. 30(2). 315–326. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact